Nexilina 200 mg film-coated tablets EFG

Spain
Brand name Nexilina 200 mg film-coated tablets EFG
Form tablets, film-coated
Active substance / Dosage
LACOSAMIDE · 200 mg
Prescription type Prescription Only Medicine
Registration number 82781

Package leaflet: Information for the user

Introduction

Package leaflet: Information for the patient

Nexilina 200 mg film-coated tablets EFG

Lacosamide

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

    • Keep this leaflet. You may need to read it again.
    • If you have any questions, ask your doctor or pharmacist.
    • This medicine has been prescribed for you only and must not be given to other people, even if they have the same symptoms as you. It may harm them.
    • If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.

Contents of the leaflet:

    1. What Nexilina is and what it is used for
    1. What you need to know before taking Nexilina
    1. How to take Nexilina
    1. Possible side effects
    1. How to store Nexilina
    1. Contents of the pack and other information

1. What Nexilina is and what it is used for

What Nexilina is

This medicine contains lacosamide, which belongs to a group of medicines called
"antiepileptic medicines". These medicines are used to treat epilepsy.

You have been prescribed this medicine to reduce the number of seizures you experience.

What Nexilina is used for

Nexilina is used:

  • as monotherapy and in combination with other antiepileptics in adults, adolescents, and children from 2 years of age to treat a certain type of epilepsy characterized by partial-onset seizures with or without secondary generalization. In this type of epilepsy, seizures affect only one side of the brain. However, they may then spread to larger areas on both sides of the brain;
  • in combination with other antiepileptics in adults, adolescents, and children from 4 years of age to treat primary generalized tonic-clonic seizures (major seizures, with loss of consciousness) in patients with idiopathic generalized epilepsy (a type of epilepsy believed to have a genetic origin).

2. What you need to know before starting to take Nexilina

Do not take Nexilina

  • if you are allergic to lacosamide or to any of the other ingredients of this medicine

(listed in section 6). If you are unsure whether you are allergic, consult your doctor.

  • if you have a heart rhythm problem called second- or third-degree AV block.

Do not take this medicine if either of the above applies to you. If you are unsure, consult your doctor or pharmacist before taking this medicine.

Warnings and precautions

Talk to your doctor before starting to use this medicine if:

  • you have thoughts of self-harm or suicide. A small number of people taking antiepileptic medicines such as lacosamide have had thoughts of self-harm or suicide. If at any time you have such thoughts, contact your doctor immediately.

  • you have a heart condition affecting your heartbeat and your pulse is often particularly slow, fast, or irregular (such as AV block, atrial fibrillation, or atrial flutter).

  • you have severe heart disease such as heart failure or have had a myocardial infarction.

  • you feel dizzy or fall frequently. Lacosamide may cause dizziness, which could increase the risk of accidental injury or falls. This means you should be cautious until you are accustomed to the effects of this medicine.

If any of the above apply to you (or you are unsure), consult your doctor or pharmacist before taking this medicine.

If you are taking Nexilina, consult your doctor if you experience a new type of seizure or a worsening of existing seizures.

If you are taking Nexilina and experience symptoms of abnormal heartbeat (such as slow, fast, or irregular heartbeat, palpitations, dyspnea (difficulty breathing), dizziness, or fainting), contact your doctor immediately (see section 4).

Children

Lacosamide is not recommended in children under 2 years of age with epilepsy characterized by partial-onset seizures, or in children under 4 years of age with generalized tonic-clonic seizures. This is because it is not yet known whether it is effective and safe in children of these age groups.

Other medicines and Nexilina

Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.

In particular, inform your doctor or pharmacist if you are taking any of the following medicines that affect the heart, as lacosamide may also affect the heart:

  • medicines used to treat heart problems.

  • medicines that may increase the "PR interval" on a heart test (ECG or electrocardiogram), such as medicines for epilepsy or pain called carbamazepine, lamotrigine, or pregabalin.

  • medicines used to treat certain types of arrhythmia or heart failure.

If any of the above apply to you (or you are unsure), speak with your doctor or pharmacist before taking this medicine.

Also inform your doctor or pharmacist if you are taking any of the following medicines, as they may increase or decrease the effect of lacosamide in your body:

  • antifungal medicines such as fluconazole, itraconazole, or ketoconazole.
  • medicines for HIV such as ritonavir.
  • medicines for bacterial infections such as clarithromycin or rifampicin.
  • a herbal medicine used to treat mild anxiety and depression called St. John's wort.

If any of the above apply to you (or you are unsure), speak with your doctor or pharmacist before taking Nexilina.

Taking Nexilina with alcohol

As a precaution, do not take this medicine with alcohol.

Pregnancy and breastfeeding

Women of childbearing age should discuss the use of contraception with their doctor.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Lacosamide is not recommended during pregnancy, as the effects of this medicine on pregnancy and the fetus are not known.

Breastfeeding is not recommended while taking Nexilina, because lacosamide passes into breast milk. Seek immediate advice from your doctor if you are pregnant or planning to become pregnant. They will help you decide whether or not to take lacosamide.

Do not stop treatment without first talking to your doctor, as this could increase seizures. Worsening of your condition may also harm the fetus.

Driving and using machines

You must not drive, ride a bicycle, or operate any tools or machinery until you know how this medicine affects you. This is because lacosamide may cause dizziness or blurred vision.

It may cause allergic reactions as it contains the colouring agent Cochineal Red A (Ponceau 4R) (E124). It may cause asthma, especially in patients allergic to acetylsalicylic acid.

3. How to take Nexilina

Follow exactly the instructions for using this medicine given by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again. Another form(s) of this medicine may be more suitable for children; consult your doctor or pharmacist.

Taking Nexilina

  • Take lacosamide twice daily, with an interval of approximately 12 hours.
  • Try to take it at about the same time each day.
  • Swallow the lacosamide tablet with a glass of water.
  • You may take lacosamide with food or separately.

Normally, you will start with a low daily dose, and your doctor will gradually increase the dose over several weeks. When you reach the dose that works well for you, known as the “maintenance dose”, you will take the same amount every day. Lacosamide is used as a long-term treatment. You should continue taking lacosamide until your doctor tells you to stop.

What dose to take

The following are the normally recommended doses of lacosamide for different age and weight groups. Your doctor may prescribe a different dose if you have kidney or liver problems.

Adolescents and children weighing 50 kg or more, and adults

When taking Nexilina alone:

The usual starting dose is 50 mg twice daily.

Your doctor may also prescribe a starting dose of 100 mg of lacosamide twice daily. Your doctor may increase your twice-daily dose by 50 mg each week, until reaching a maintenance dose between 100 mg and 300 mg twice daily.

When taking Nexilina with other antiepileptic medicines:

The usual starting dose is 50 mg twice daily.

Your doctor may increase your twice-daily dose by 50 mg each week, until reaching a maintenance dose between 100 mg and 200 mg twice daily.

If you weigh 50 kg or more, your doctor may start lacosamide treatment with a single “loading” dose of 200 mg. You would then start taking the regular maintenance dose 12 hours later.

Children and adolescents weighing less than 50 kg

  • In the treatment of partial-onset seizures: note that lacosamide is not recommended for children under 2 years of age.
  • In the treatment of primary generalized tonic-clonic seizures: note that lacosamide is not recommended for children under 4 years of age.

The dose depends on body weight. Treatment is usually started with the oral solution, and only switched to tablets if the patient is able to swallow them and can achieve the correct dose using tablets of different strengths. Your doctor will prescribe the pharmaceutical form best suited to you.

If you take more Nexilina than you should

If you have taken more lacosamide than you should, contact your doctor immediately. Do not attempt to drive.

You may experience:

  • dizziness;
  • feeling sick (nausea) or being sick (vomiting);
  • seizures (fits), heart rhythm problems such as slow, fast or irregular pulse, coma, or low blood pressure with tachycardia and sweating.

If you forget to take Nexilina

  • If you forget to take a dose within 6 hours of your scheduled dose, take it as soon as you remember.

  • If you forget to take a dose more than 6 hours after your scheduled dose, do not take the missed dose; instead, take lacosamide at your next usual time.

  • Do not take a double dose to make up for a missed dose.

If you stop taking Nexilina

  • Do not stop taking lacosamide without telling your doctor, as epilepsy may return or worsen.
  • If your doctor decides to stop your lacosamide treatment, you will be given instructions on how to gradually reduce the dose.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, lacosamide may cause adverse effects, although not everyone experiences them.

Nervous system-related adverse effects, such as dizziness, may be greater after a single "loading" dose.

Inform your doctor or pharmacist if you experience any of the following effects:

Very common: may affect more than 1 in 10 patients

  • Headache;
  • Feeling dizzy or sick (nausea);
  • Double vision (diplopia).

Common: may affect up to 1 in 10 patients

  • Brief jerks of a muscle or group of muscles (myoclonic jerks);
  • Difficulty coordinating movements or walking;
  • Problems maintaining balance, tremor, tingling (paraesthesia), or muscle spasms, falling easily and bruising;
  • Memory, thinking, or word-finding difficulties, confusion;
  • Rapid, uncontrolled eye movements (nystagmus), blurred vision;
  • Sensation of dizziness (vertigo), feeling of drunkenness;
  • Dizziness (vomiting), dry mouth, constipation, indigestion, excessive gas in the stomach or intestines, diarrhoea;
  • Decreased sensation, difficulty speaking, attention disturbance;
  • Ringing in the ears such as buzzing, ringing, or whistling;
  • Irritability, sleep problems, depression;
  • Drowsiness, tiredness or weakness (asthenia);
  • Itching, rash.

Uncommon: may affect up to 1 in 100 patients

  • Decreased heart rate, palpitations, irregular pulse, or other changes in the heart's electrical activity (conduction disorder);
  • Exaggerated feeling of well-being, seeing and/or hearing things that are not real;
  • Allergic reaction to the medicine, hives;
  • Blood tests may show abnormalities in liver function tests, liver damage;
  • Thoughts of self-harm or suicide, or suicide attempt: inform your doctor immediately;
  • Feeling angry or agitated;
  • Abnormal thoughts or loss of sense of reality;
  • Severe allergic reactions causing swelling of the face, throat, hands, feet, ankles, or lower legs;
  • Fainting.
    • Abnormal involuntary movements (dyskinesia).

Frequency not known: cannot be estimated from available data

  • Abnormally fast heartbeat (ventricular tachyarrhythmia);
  • Sore throat, high temperature, and increased frequency of infections. Blood tests may show a severe decrease in a specific type of white blood cells (agranulocytosis);
  • Serious skin reaction, which may include high temperature and other flu-like symptoms, rash on the face, widespread rash with swollen lymph nodes (enlarged lymph nodes). Blood tests may show increased liver enzyme levels and an increase in a type of white blood cells (eosinophilia);
  • A widespread rash with blisters and skin peeling, especially around the mouth, nose, eyes, and genitals (Stevens-Johnson syndrome), and a more severe form causing skin peeling over more than 30% of the body surface (toxic epidermal necrolysis);
  • Seizures.

Other adverse effects in children

Additional adverse effects observed in children were fever (pyrexia), runny nose (nasopharyngitis), sore throat (pharyngitis), eating less than usual (decreased appetite), behavioural changes, acting differently than normal (abnormal behaviour), and lack of energy (lethargy). Drowsiness (somnolence) is a very common side effect in children and may affect more than 1 in 10 children.

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. They can also be reported directly via the Spanish Pharmacovigilance System for Human Medicines website: www.notificaRAM.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Nexilina

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the carton and blister after CAD/EXP. The expiry date refers to the last day of the month indicated.

This medicine requires no special storage conditions.

Medicines must not be disposed of via wastewater or household waste. Dispose of unused medicines and their packaging at the SIGRE collection point at your pharmacy. If you have any doubts, ask your pharmacist how to dispose of medicines and packaging you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of Nexilina

The active substance is lacosamide.

Each Nexilina 200 mg tablet contains 200 mg of lacosamide.

The other components are:

Tablet core: microcrystalline cellulose, hydroxypropylcellulose, low-substituted hydroxypropylcellulose, anhydrous colloidal silica, crospovidone, magnesium stearate.

Coating: poly(vinyl alcohol), macrogol, talc, titanium dioxide (E171),
brilliant blue FCF (E133) and cochineal red A (Ponceau 4R) (E124).

Appearance of the product and contents of the pack

Nexilina 200 mg are film-coated, oval, blue tablets, marked with “200” on one side and smooth on the other. Approximate dimensions: 7.8 x 15.6 mm.

Nexilina 200 mg is available in blister packs containing 56 film-coated tablets.

Marketing Authorization Holder

Adventia Pharma, S.L.
Calle Viera y Clavijo, 30, 2º
35002 Las Palmas de Gran Canaria (Spain)

Local Representative

Atika Pharma, S.L.
Calle Viera y Clavijo, 30, 2º
35002 Las Palmas de Gran Canaria (Spain)

Manufacturer

Merckle GmbH,
Blaubeuren,
Germany

Or

TEVA Gyógyszergyár Zrt.,
Pallagi út 13
H-4042, Debrecen
Hungary

Date of the most recent review of this leaflet: July 2022

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS): http://www.aemps.gob.es/